Edwards Lifesciences Corp
(EW)CIK 1099800 · SEC filings only
harness minimum not met
Not enough resolved promises to grade
0 of the 4 resolved buyback promises needed to publish a reliability grade. Here's what we're tracking — we never show a grade we can't back with receipts.
buyback history
Free scorecards show the 12 most recent resolved buyback promises. See the complete multi-year record with Pro.
See Pro →Open promises (1)
now totals approximately $2.1 billion
grade
Sector median (Industrial Applications and Services): B+ across 28 graded companies
Resolved promises
Full say-do history
Free scorecards show the 12 most recent resolved guidance promises. See the complete multi-year record with Pro.
See Pro →Guidance by basis
38 of 77 guidance figures that were graded or dropped for basis could not be graded on the same basis (49%). Guidance marked “not judged” is in neither number.
| Guidance type | Said | Graded | Dropped | Other |
|---|---|---|---|---|
| Revenue · non-GAAPcannot be graded | 9 | 0 | 5 | 4 |
| Revenue · basis not stated | 60 | 39 | 0 | 21 |
| EPS · non-GAAPcannot be graded | 60 | 0 | 33 | 27 |
| EPS · basis not statedcannot be graded | 1 | 0 | 0 | 1 |
Said counts every revenue and EPS guidance figure on record. Dropped counts figures whose period was reported but which have no comparable GAAP actual in SEC XBRL. Other covers open, superseded, withdrawn and otherwise unresolved figures. The coverage note below counts every figure shown but not graded, including figures whose period has not been reported, so it can be larger.
Guidance shown, not graded (71)
We show what was said — with its source filing — but never score it. The line under each statement says why.
- revenue guidance fy · Apr 23, 2026Raising FY 2026 constant currency 2 sales growth guidance to 9% to 11%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Apr 23, 2026For the second quarter of 2026, the company projects total sales to be between $1.66 and $1.74 billion and adjusted EPS of $0.70 to $0.76Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Apr 23, 2026Raising FY 2026 adjusted 2 EPS guidance midpoint; new range of $2.95 to $3.05Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Oct 30, 2025adjusted EPS of $0.58 to $0.64Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Oct 30, 2025now expects adjusted EPS to be within the range of $2.56 to $2.62Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Jul 24, 2025The company now expects full-year adjusted EPS to be at the high end of its original range of $2.40 to $2.50Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Jul 24, 2025adjusted EPS of $0.54 to $0.60Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Apr 23, 2025maintains its full-year operating margin guidance of 27% to 28% and EPS guidance of $2.40 to $2.50Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Apr 23, 2025adjusted EPS of $0.59 to $0.65Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Feb 11, 2025Reiterating 2025 constant currency sales growth of 8% - 10%Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Feb 11, 2025adjusted EPS of $0.58 to $0.64Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Feb 11, 2025adjusted EPS of $2.40 - $2.50Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Oct 24, 2024Q4 EPS of $0.53 to $0.57Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Apr 25, 2024The company is maintaining its full-year 2024 adjusted earnings per share guidance of $2.70 to $2.80Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Apr 25, 2024adjusted EPS of $0.67 to $0.71Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Feb 6, 2024adjusted EPS of $0.62 to $0.66Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Feb 6, 2024the company continues to expect full year 2024 adjusted earnings per share of $2.70 to $2.80Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Feb 6, 2024Full year 2024 sales are expected to grow 8 to 10 percentUnverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Oct 25, 2023the company continues to expect full year 2023 adjusted earnings per share of $2.50 to $2.60.Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Oct 25, 2023The company continues to expect full-year total company and TAVR sales growth to be in the 10 to 13 percent range on a constant currency basis.Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Oct 25, 2023diluted earnings per share of $0.60 and $0.66.Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Jul 26, 2023the company is lifting its full year 2023 adjusted earnings per share guidance to $2.50 to $2.60Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Jul 26, 2023The company now expects full-year total company and TAVR sales growth to be in the 10 to 13 percent range on a constant currency basisUnverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Jul 26, 2023adjusted EPS of $0.55 to $0.61Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Apr 26, 2023adjusted EPS of $0.62 to $0.68Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Apr 26, 2023the company is lifting its full year 2023 adjusted earnings per share guidance to $2.48 to $2.60Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Jan 31, 2023we expect 9 to 12 percent sales growth in 2023Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Jan 31, 2023adjusted EPS of $0.58 to $0.64Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Jan 31, 2023the company continues to expect full year 2023 adjusted earnings per share of $2.45 to $2.60Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Oct 27, 2022Edwards now expects full year adjusted EPS of $2.40 to $2.50Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Oct 27, 2022The company expects reported sales and adjusted EPS to be similar to the third quarterUnverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Oct 27, 2022For the fourth quarter of 2022, Edwards projects year-over-year and sequential sales growth in constant currencyNot judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- eps guidance q · Jul 28, 2022adjusted EPS of $0.58 to $0.66Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Jul 28, 2022The company now expects full year adjusted EPS guidance at the bottom end of its original guidance range of $2.50 to $2.65Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Apr 26, 2022Full year 2022 sales are expected to grow at a low double-digit underlying rate to $5.5 to $6.0 billionUnverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Apr 26, 2022adjusted EPS of $0.61 to $0.69Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Apr 26, 2022the company continues to expect full year 2022 adjusted earnings per share of $2.50 to $2.65Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Jan 26, 2022adjusted EPS of $0.54 to $0.62Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Jan 26, 2022the company continues to expect full year 2022 adjusted earnings per share of $2.50 to $2.65Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Oct 27, 2021adjusted EPS of $0.53 to $0.59Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Oct 27, 2021adjusted earnings per share guidance at the high end of $2.07 to $2.27Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Jul 29, 2021adjusted EPS of $0.50 to $0.56Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Jul 29, 2021The company is raising full year 2021 adjusted earnings per share guidance to the high end of the previous $2.07 to $2.27 rangeUnverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Apr 20, 2021The company is raising full year 2021 adjusted earnings per share to $2.07 to $2.27 from $2.00 to $2.20.Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Apr 20, 2021adjusted EPS of $0.54 to $0.60.Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Jan 27, 2021the company continues to expect full year 2021 adjusted earnings per share of $2.00 to $2.20.Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Jan 27, 2021adjusted EPS of $0.43 to $0.50.Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Oct 22, 2020The company is raising the bottom end of full-year 2020 adjusted earnings per share guidance to $1.85 to $1.95Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Oct 22, 2020the company anticipates year-over-year underlying sales growth similar to the third quarterUnverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Jul 23, 2020The company now expects full-year 2020 adjusted earnings per share of $1.75 to $1.95 on a post-split basisUnverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Apr 23, 2020the company now expects full year 2020 adjusted earnings per share of $4.75 to $5.25Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Oct 23, 2019the company raised its full year 2019 adjusted earnings per share guidance to $5.50 to $5.65Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Apr 23, 2019adjusted EPS of $1.27 to $1.37Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Apr 23, 2019the company raised its full year 2019 adjusted earnings per share guidance to $5.10 to $5.35Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Jan 31, 2019adjusted EPS of $1.15 to $1.25.Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Jan 31, 2019the company continues to expect full year 2019 adjusted earnings per share to be between $5.05 and $5.30.Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Jul 26, 2018adjusted EPS of $0.93 to $1.03Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Jul 26, 2018the company is raising its estimate for 2018 adjusted earnings per share to be between $4.60 and $4.75Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Feb 1, 2018the company now expects its estimate for 2018 adjusted earnings per share to be between $4.43 and $4.63Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Feb 1, 2018adjusted EPS of $1.04 to $1.14Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Jul 26, 2017the company projects underlying sales, adjusting for the impact of Germany stocking sales consumption, to be between $810 and $850 millionUnverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Jul 26, 2017raising its estimate for 2017 a djusted earnings per share to $3.65 to $3.85Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Jul 26, 2017adjusted earnings per share of $0.80 to $0.90Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Feb 1, 2017adjusted earnings per share to be between $3.30 and $3.45Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Feb 1, 2017adjusted earnings per share to be between $0.79 and $0.89Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Oct 25, 2016adjusted earnings per share to be between $0.67 and $0.77Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Oct 25, 2016the company now expects adjusted earnings per share to be between $2.82 and $2.92Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Apr 26, 2016the company now expects adjusted earnings per share to be between $2.67 and $2.77Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Apr 26, 2016adjusted earnings per share to be between $0.67 and $0.73Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Oct 26, 2015diluted earnings per share, excluding special items, to be between $1.11 and $1.21Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Oct 26, 2015The company is increasing its guidance for full year 2015 diluted earnings per share, excluding special items, to a range of $4.43 to $4.53Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
Open promises (1) · 19 superseded
Edwards now expects total company sales of $6.5 to $6.9 billion
the company now expects full year 2023 sales to be at the high end of its $5.6 to $6.0 billion range
Full year 2023 sales are expected to grow 9 to 12 percent to $5.6 to $6.0 billion
Increasing Edwards sales growth guidance to 9-10%
Overall, 2019 sales guidance for total Edwards remains unchanged.
sales of $5.9 billion to $6.1 billion
the company continues to expect sales to be between $3.0 and $3.4 billion
Full year 2024 sales are expected to grow 8 to 10 percent to $6.3 to $6.6 billion
Edwards increased its sales estimate to be at the higher end of its $3.5 to $3.9 billion guidance
Overall, the company now expects full year 2021 sales of $5.2 to $5.4 billion
Overall, full year 2021 sales guidance for Edwards remains at $4.9 to $5.3 billion.
Edwards now expects total company sales of $5.7 to $6.1 billion in 2025
Overall, full year 2021 sales guidance for Edwards remains $4.9 to $5.3 billion.
Overall, 2019 sales guidance for Edwards of $3.9 to $4.3 billion remains unchanged.
Full year 2023 sales are expected to grow 10 to 12 percent
the company now expects full year 2022 sales of $5.35 to $5.55 billion
For the full year 2016, the company now expects sales to be between $2.7 and $3.0 billion
Overall, 2020 sales guidance for Edwards is now expected to be $4.0 to $4.5 billion
the company now expects full-year 2024 sales growth to be at the high end of the prior guidance of 8 to 10% and $6.3 to $6.6 billion
Full year 2022 sales are expected to grow at a low double-digit rate to $5.5 to $6.0 billion.
Credibility timeline
Timeline as a list
- Oct 27, 2023IN LINEFor the third quarter of 2023, the company projects total sales to be between $1.44 and $1.52 billion
- Feb 12, 2024ABOVEFor the fourth quarter of 2023, the company projects total sales to be between $1.45 and $1.53 billion
- Feb 12, 2024IN LINEthe company now expects full year 2023 sales to be in the $5.9 to $6.1 billion range
- Apr 29, 2024IN LINEFor the first quarter of 2024, the company projects total sales to be between $1.53 and $1.61 billion
- Jul 31, 2024BELOWFor the second quarter of 2024, the company projects total sales to be between $1.62 and $1.70 billion
- Feb 28, 2025IN LINEEdwards' full year sales growth guidance of 8 to 10% remains unchanged
- Feb 28, 2025IN LINEEdwards expects fourth quarter sales of $1.33 to $1.39 billion
- May 6, 2025IN LINEthe company projects total sales to be between $1.35 and $1.43 billion
- Aug 6, 2025ABOVEFor the second quarter of 2025, the company projects total sales to be between $1.45 and $1.53 billion
- Nov 5, 2025ABOVEthe company projects total sales to be between $1.46 and $1.54 billion
- Feb 25, 2026IN LINEprojects total sales to be between $1.51 and $1.59 billion
- Feb 25, 2026ABOVEIncreasing sales growth guidance to high end of 9-10%